| Literature DB >> 26900848 |
Liang Yan1, Su Qu1,2, Gang Liu3, Lei Liu3, Yao Yu3, Guohui Ding3, Yanfeng Zhao4, Yixue Li3, Youhua Xie1, Junqi Zhang1, Di Qu1.
Abstract
Primary duck hepatocytes (PDH) displays differential susceptibility to duck hepatitis B virus when maintained in the media supplemented with fetal bovine serum or dimethyl sulfoxide (DMSO) which has been widely used for the maintenance of hepatocytes, and prolonging susceptibility to hepadnavirus. However the mechanism underlying maintenance of susceptibility to hepadnavirus by DMSO treatment remains unclear. In this study, a global transcriptome analysis of PDHs under different culture conditions was conducted for investigating the effects of DMSO on maintenance of susceptibility of PDH to DHBV in vitro. The 384 differential expressed genes (DEGs) were identified by comparisons between each library pair (PDHs cultured with or without DMSO or fresh isolated PDH). We analyzed canonical pathways in which the DEGs were enriched in Hepatic Fibrosis / Hepatic Stellate Cell Activation, Bile Acid Biosynthesis and Tight Junction signaling. After re-annotation against human genome data, the 384 DEGs were pooled together with proteins belonging to hepatitis B pathway to construct a protein-protein interaction network. The combination of decreased expression of liver-specific genes (CYP3A4, CYP1E1, CFI, RELN and GSTA1 et al) with increased expression of hepatocyte-dedifferentiation-associated genes (PLA2G4A and PLCG1) suggested that in vitro culture conditions results in the fading of hepatocyte phenotype in PDHs. The expression of seven DEGs associated with tight junction formation (JAM3, PPP2R2B, PRKAR1B, PPP2R2C, MAGI2, ACTA2 and ACTG2) was up-regulated after short-term culture in vitro, which was attenuated in the presence of DMSO. Those results could shed light on DHBV infection associated molecular events affected by DMSO.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26900848 PMCID: PMC4763071 DOI: 10.1371/journal.pone.0149702
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Intracellular and extracellular viral DNA detection for PDH maintained in different culture media.
(A) The Con-PDH, DMSO-8d PDH and FBS-8d PDH (Two lanes of FBS 8d were transformed from a different gel.) were infected with DHBV at a multiplicities of genome equivalents (MGE) of 100 on the 1st or 8th d post-inoculation. (B) The supernatants from the PDH maintained in the different culture media were collected and DHBV DNA was extracted and quantified by qPCR. The cccDNA (C) and core DNA (D) were extracted and analyzed by Southern blot hybridization. RC, relaxed circular DNA; DSL, double-stranded linear DNA; SS, single-stranded DNA; cccDNA, covalently closed circular DNA.
Summary of sequencing reads mapped to the Anas platyrhynchos reference genome.
| Sample Name | PDH from duckling (NO.) | Raw Data | Processed Data | Mapping data | |||
|---|---|---|---|---|---|---|---|
| Total Reads (million) | Total Bases (Gb) | Total Reads (million) | Total Bases (Gb) | Mapped Reads (million) | Mapping Rate | ||
| 1 | 26.40 | 2.22 | 23.26 | 2.04 | 20.79 | 0.89 | |
| 2 | 18.92 | 1.58 | 16.59 | 1.45 | 14.63 | 0.88 | |
| 3 | 20.63 | 1.72 | 18.06 | 1.58 | 16.01 | 0.89 | |
| 1 | 28.49 | 2.39 | 25.07 | 2.20 | 22.48 | 0.90 | |
| 2 | 20.53 | 1.72 | 18.06 | 1.58 | 16.21 | 0.90 | |
| 3 | 32.76 | 2.83 | 30.08 | 2.68 | 26.48 | 0.88 | |
| 1 | 23.63 | 1.98 | 20.72 | 1.81 | 18.48 | 0.89 | |
| 2 | 25.78 | 2.16 | 22.63 | 1.98 | 20.03 | 0.89 | |
| 3 | 23.10 | 2.00 | 21.26 | 1.90 | 18.78 | 0.88 | |
| 220.25 | 18.61 | 195.74 | 17.22 | 173.89 | 0.89 | ||
Fig 2Expression pattern analysis of DEGs by PCA plot, Venn diagram and K-mean clustering.
(A) PCA analysis of the transcriptomic data from RNA-seq. Single biological replicates are represented by dots, and PDH under different culture conditions are designated using separate colors. (B) Venn diagram of DEGs under different culture conditions. Three comparisons were performed between each library pair (Con-PDH, FBS-8d and DMSO-8d) and genes with an adjusted P value less than 0.05 and a change in transcription level of at least 2-fold were deemed to be differentially expressed. Among the comparisons, the number of overlapping genes is shown by the Venn diagram. (C) A heat map of the DEGs in PDH under various culture conditions. The columns represent triplicate samples of PDH under the three culture conditions and the relative expression level of genes are indicated by the color. Two significant K-mean clustering of the genes according to their expression pattern are shown.
Expression of five genes validated by RT-qPCR.
| Genes | Functions of encoded proteins | Ratio detected by qRT-PCR | Ratio detected by RNA-seq | ||||
|---|---|---|---|---|---|---|---|
| DMSO-8d/Con | FBS-8d/Con | DMSO-8d/FBS-8d | DMSO-8d/Con | FBS-8d/Con | DMSO-8d/FBS-8d | ||
| Main protein of human blood plasma specifically synthesized in hepatocytes. | 0.02 | 0.01 | 8.00 | 0.05 | 0.00 | 19.24 | |
| Belonging to the superfamily of lipocalin transport proteins and may play a role in the regulation of inflammatory processes. | 0.09 | 0.02 | 4.50 | 0.50 | 0.12 | 4.30 | |
| DHBV docking receptor. | 0.53 | 0.69 | 0.77 | 0.77 | 1.20 | 0.64 | |
| Involving in the membrane fusion of DHBV infection. | 0.11 | 0.07 | 1.57 | 1.41 | 0.56 | 2.52 | |
| An enzyme in the endosome which can cleave DHBV large surface protein. | 0.95 | 0.46 | 2.07 | 0.53 | 0.72 | 0.73 | |
* Relative expression of genes were calculated based on 2-ΔΔCT using beta-actin as house-keeping gene.
**Ratio of FPKM value.
Fig 3DEGs-associated canonical pathways as indicated by IPA.
Canonical pathways were analyzed by IPA software using genes that were differentially expressed in PDH under the different culture conditions. The significance (P value, yellow line) of the pathways was calculated using Fisher’s Exact Test, and the percentages of down-regulated (green bar) and up-regulated genes (red bar), respectively, in each pathway are indicated.
Fig 4Interaction networks between DEGs and genes involved in the Hepatitis B pathway.
The proteins encoded by DEGs (red, green or yellow nodes) or involved in the Hepatitis B pathway (purple nodes) in the KEGG database were extracted to construct a protein–protein interaction network. The lines in the network represent protein–protein interactions, including binding/association, phosphorylation, activation, and inhibition. Proteins encoded by up-regulated or down-regulated DEGs are indicated in red or green, respectively.
Role of the differentially expressed genes in virus infection or cell process.
| AccID | Gene Description (Duck) | Gene Description (Blast to Human) | FPKM value | Expression | Function indicated in virus infection or cell process | References | ||
|---|---|---|---|---|---|---|---|---|
| FTH1 | Ferritin | Ferritin heavy chain | 21370 | 8968 | 2102 | down | Serum ferritin used as a predictor of host response to hepatitis B virus infection; HCV infection increased levels of serum ferritin. | Lustbader ED, et al., Science, 1983, 220:423–425 Garrido Serrano A, et al., Rev Esp Enferm Dig, 2001, 93:639–48 Shan Y, et al., Clin Infect Dis, 2005, 40:834–41 |
| CREB3L1 | Uncharacterized protein | highly similar to Homo sapiens cAMP responsive element binding protein 3-like 1 (CREB3L1) | 1 | 2 | 25 | up | Activated in response to virus infection to inhibit proliferation of virus-infected cells; proteolytically cleaved upon viral infection. | Denard B, et al., Cell Host Microbe, 2011, 10:65–74 Ye J,Biochim Biophys Acta, 2013, 1828:2926–32 |
| FDPS | Uncharacterized protein | Farnesyl pyrophosphate synthase | 405 | 189 | 73 | down | Reduction of FPPS levels inhibited influenza virus release and replication. | Wang X, et al., Cell Host Microbe, 2007, 2:96–105. |
| IRS2 | insulin receptor substrate 2 | Insulin receptor substrate-2 | 8 | 3 | 1 | down | Down-regulated by HCV infection. | Kawaguchi T, et al., Am J Pathol, 2004, 165:1499–508. |
| PLA2G4A | Uncharacterized protein | highly similar to Homo sapiens phospholipase A2, group IVA (cytosolic, calcium-dependent) (PLA2G4A) | 0 | 5 | 53 | up | Being crucial for the production of highly infectious HCV progeny; up-regulated in the cell lines infected with influenza virus. | Menzel N, et al., 2012, PLoS Pathog, 8: e1002829. Billharz R, et al., 2009, J Virol, 83:10557–10570. |
| CFI | Uncharacterized protein | Complement factor I | 22 | 7 | 1 | down | An essential proteinase for regulating the complement cascade. | Ullman CG, et al., Mol Immunol, 1998, 35:503–12. |
| RELN | Uncharacterized protein | Reelin | 6 | 3 | 0 | down | Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma. | Okamura Y, et al., Ann Surg Oncol, 2011, 18:572–9. |
| CES2 | LOC101790670 | Carboxylesterase 2 (intestine, liver) | 64 | 14 | 1 | down | Being responsible for the hydrolysis or transesterification of various xenobiotics and the major intestinal enzyme and functions in intestine drug clearance. | Taketani M, et al., Life Sci. 2007, 81(11):924–32 |
| CYP3A4 | LOC101799795 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | 552 | 22 | 0 | down | Being the most abundantly expressed drug-metabolizing P450 enzyme in human liver and catalyze many reactions involved in drug metabolism. | Raucy JL, et al., Drug Metab Dispos. 2003, 31(5):533–9. Martínez-Jiménez CP, et al., Curr Drug Metab, 2007,8(2):185–94. |
| ADH1A | Uncharacterized protein | Alcohol dehydrogenase 1A (class I), alpha polypeptide | 132 | 60 | 11 | down | Catalyzing the oxidation of alcohols to aldehydes. | Lange LG, Biochemistry, 1976, 15(21): 4687–93. |
| GSTA1 | LOC101797566 | Glutathione S-transferase A1 | 601 | 209 | 9 | down | Function in the detoxification of electrophilic compounds by conjugation with glutathione. | Karpusas M, et al., PLoS One. 2013, 8(2): e56337 |
| CYP2E1 | LOC101796596 | Cytochrome P450 family 2 subfamily E polypeptide 1 (vase tunicate). | 142 | 42 | 2 | down | Catalyzing many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. | Deka M, et al., World J Gastroenterol. 2010, 16(38):4800–8. |
| RSAD2 | Radical S-adenosyl methionine domain-containing protein 2 | Highly similar to Homo sapiens viperin (cig5) | 124 | 15 | 1 | down | A cellular protein which could inhibit many DNA and RNA viruses such as CHIKV, HCMV, HCV, DENV, WNV, SINV, influenza, HIV LAI strain. | Teng TS, et al., J Clin Invest, 2012, 122:4447–60; Cho H, et al., Nat Med. 2013;19(4):458–64; Thomas E, et al., Gastroenterology, 2012,142:978–88 |
| CMPK2 | Uncharacterized protein | Mitochondrial cytidine monophosphate (UMP-CMP) kinase 2 | 75 | 22 | 2 | down | Antiviral ISGs in primary neurons induced by IFN-βtreatment. | Li J, et al., Glia, 2011, 59:58–67 |
| RIPK2 | Uncharacterized protein | Highly similar to Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) | 40 | 16 | 7 | down | Modulated by HBeAg which supporting the concept that HBeAg could impair both innate and adaptive immune responses to promote chronic HBV infection; NOD2-RIPK2 signaling in protection against virally triggered immunopathology. | Wu S, et al., J Infect Dis.2012, 206:415–20; Lupfer C, et al., Nat Immunol, 2013, 14: 480–488 |
| ACTA2 | Uncharacterized protein | Highly similar to Actin, aortic smooth muscle | 13 | 93 | 819 | up | Playing a role in cell motility, structure and integrity. | Lee HW, et al., Clin Cancer Res, 2013, 19:5879–89. |
| JAM3 | Uncharacterized protein | Junctional adhesion molecule C | 0 | 2 | 9 | up | Interact with the coxsackievirus and adenovirus receptor (CAR). | Mirza M, et al., Exp Cell Res. 2006, 312:817–30. |
| PPP2R2B | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform | 0 | 2 | 22 | up | Involved in the negative control of cell growth and division. | Cheng WT, et al., BMC Cell Biol, 2009,10:91 |
| PRKAR1B | Uncharacterized protein | Protein kinase, cAMP-dependent, regulatory, type I, beta, isoform CRA_b | 1 | 10 | 63 | up | Controling many biochemical events in the cell including regulation of metabolism, ion transport, and gene transcription. | Elphinstone MS, et al., Clin Endocrinol (Oxf), 2004, 61:716–23. |
| PPP2R2C | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform | 0 | 3 | 10 | up | Involved in the negative control of cell growth and division. | Backx L, et al., Eur J Med Genet, 2010, 53:239–43. |
| MAGI2 | Uncharacterized protein | Highly similar to WW andPDZ domain-containing protein 2 | 0 | 0 | 1 | up | Acting as scaffold molecule at synaptic junctions by assembling neurotransmitter receptors and cell adhesion proteins. | Wapenaar MC, et al., Gut, 2008, 57:463–7 |
| ACTG2 | Actin, gamma-enteric smooth muscle | cDNA FLJ42347 fis, clone UTERU2003399 | 13 | 101 | 271 | up | Involved in various types of cell motility and in the maintenance of the cytoskeleton. | Citi S, et al., Ann N Y Acad Sci, 2009,1165:88–98 |
| CLDN2 | Claudin | Claudin-2 | 16 | 4 | 1 | down | Expressed in an organ-specific manner and regulate tissue-specific physiologic properties of tight junctions. | Wu F, et al., Exp Eye Res, 2008, 87:214–25; Rosenthal R et al., J Cell Sci, 2010,123:1913–21; Van Itallie CM, et al., Mol Biol Cell, 2009, 20:3930–40. |
Fig 5Differential DHBV attachment to PDH maintained under different conditions.
PDH with differential susceptibility was pretreated with nocodazole and infected with DHBV at a MGE of 500. The DHBV attached to PDH were quantified by qPCR. Anti-Dpres/s or IgG were used as control. The asterisk represents a significant difference (t test, P value<0.05).
Primers for detection of DHBV DNA and differential expressed genes.
| Gene | Sense | Primer Sequences | Primer Location | Designed based on |
|---|---|---|---|---|
| F | 2586–2605 | DHBV genome | ||
| R | 2666–2685 | NC_001344.1 | ||
| probe | 2606–2632 | |||
| F | 1485–1503 | NM_00131039 | ||
| R | 1572–1589 | 4.1 | ||
| F | 308–329 | XM_00501478 | ||
| R | 398–416 | 1.2 | ||
| F | 2582–2599 | NM_00131038 | ||
| R | 2647–2665 | 2.1 | ||
| F | 2026–2043 | NM_00131036 | ||
| R | 2166–2183 | 7.1 | ||
| F | 1251–1269 | XM_01310036 | ||
| R | 1315–1332 | 7.1 | ||
| F | 784–801 | NM_00131042 | ||
| R | 847–864 | 1.1 |
* Designed based on assembled transcripts in RNA-seq
**F: forward primer, R: reverse primer, Probe: FAM™ dye-labeled TaqMan MGB probe.